← Leaderboards
Andrew Coop
University Of Maryland Baltimore
$3,251,315
Attributed
$3,251,315
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $386.4K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,251,315 · 3
By mechanism
R01$2,723,620 · 2
K02$527,695 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Christopher W Cunningham$790,011
- Ruixin Zhang$1,641,268
Others in their field
Top investigators on “Opioid Receptor”
- Charles P France · University Of Texas Hlth Science Center$30,774,689
- Jeffrey Reich · Sparian Biosciences, Inc.$28,894,251
- Kurt Francis Hauser · University Of Kentucky$25,730,611
- Xinhua Li · Nano Terra, Inc.$21,217,757
- Sandra D. Comer · New York State Psychiatric Institute$20,243,615
- Mark E. Von Zastrow · University Of California, San Francisco$19,881,705
Research focus
Opioid ReceptorAnalogLigandsMorphinansResearch Project GrantsBaseOpioidMorphineAgonistDesignAnalgesicsPainDoseEtorphineMethodologyDrug Design /Synthesis /ProductionChronicMolecular DynamicsInhibitor /AntagonistNaltrindoleChronic PainClinical TreatmentBinding (Molecular Function)Indoles
Grant awards (17)
Opiods with Delta Antagonist and Mu Agonist Activity$271,682
R01 · FY2012 · DA · contact PI
Opiods with Delta Antagonist and Mu Agonist Activity$294,972
R01 · FY2011 · DA · contact PI
Opiods with Delta Antagonist and Mu Agonist Activity$262,935
R01 · FY2010 · DA · contact PI
Opiods with Delta Antagonist and Mu Agonist Activity$24,010
R01 · FY2010 · DA · contact PI
Opiods with Delta Antagonist and Mu Agonist Activity$265,591
R01 · FY2009 · DA · contact PI
Reversing the toxic effects of drugs of abuse$113,976
K02 · FY2009 · DA · contact PI
Opiods with Delta Antagonist and Mu Agonist Activity$276,841
R01 · FY2008 · DA · contact PI
Reversing the toxic effects of drugs of abuse$109,592
K02 · FY2008 · DA · contact PI
Reversing the toxic effects of drugs of abuse$105,377
K02 · FY2007 · DA · contact PI
Reversing the toxic effects of drugs of abuse$101,323
K02 · FY2006 · DA · contact PI
OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITY$222,750
R01 · FY2005 · DA
Reversing the toxic effects of drugs of abuse$97,427
K02 · FY2005 · DA
OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITY$222,750
R01 · FY2004 · DA
OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITY$222,750
R01 · FY2003 · DA
OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITY$222,750
R01 · FY2002 · DA
OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITY$220,325
R01 · FY2001 · DA
DYNORPHIN ANALOGS AS KAPPA OPIOID RECEPTOR ANTAGONISTS$216,264
R01 · FY2000 · DA